NCT06455644 Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion Status RECRUITING Phase NA
NCT06449469 The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Status ACTIVE_NOT_RECRUITING Phase NA
NCT06446531 Prevention of Progression of Prediabetes, Obesity and CV Risk Status RECRUITING Phase PHASE1
NCT06446076 Feedback Using behaviOral econOmic Theories on STEP countS in Cardiovascular Disease Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT06444711 OPTIMISation of Cardio-renal-metabolic-pulmonary Disease Guideline Adherence in High Risk Community Dwelling Individuals Status ACTIVE_NOT_RECRUITING Phase NA
NCT06435611 Adiposity, Cardiometabolic and Neurocognitive Health Among Ethnic Groups: a Feasibility and Pilot Study Status RECRUITING Phase N/A
NCT06432153 Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation Status NOT_YET_RECRUITING Phase N/A
NCT06424119 Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs Status RECRUITING Phase NA
NCT06423365 A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication. Status ACTIVE_NOT_RECRUITING Phase NA
NCT06422741 Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers Status RECRUITING Phase NA
NCT06420479 The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality Status RECRUITING Phase N/A
NCT06416267 Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) Status NOT_YET_RECRUITING Phase N/A
NCT06412536 Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility Status RECRUITING Phase N/A
NCT06412250 A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry) Status RECRUITING Phase N/A
NCT06411340 Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR) Status NOT_YET_RECRUITING Phase N/A
NCT06409481 Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA) Status NOT_YET_RECRUITING Phase N/A